Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions

BMC Veterinary Research

Volumn 5, Issue , 2009, Pages

  Barrey, Eric ^a,c   Mucher, Elodie ^a   Jeansoule, Nicolas ^e   Larcher, Thibaut ^b   Guigand, Lydie ^b   Herszberg, Bérénice ^c   Chaffaux, Stéphane ^c   Guérin, Gérard ^c   Mata, Xavier ^c   Benech, Philippe ^d   Canale, Marielle ^d   Alibert, Olivier ^e   Maltere, Péguy ^e   Gidrol, Xavier ^e  

^a Val d'Essonne University   (France)

^b INRA UMR 703   (France)

^c UMR1313 GÉNÉTIQUE ANIMALE ET BIOLOGIE INTÉGRATIVE   (France)

^d Genoscience Pharma   (France)

^e DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE;

GLYCOGEN; POLYSACCHARIDE;

ANIMAL; ANIMAL DISEASE; ANOXIA; ARTICLE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOTYPE; HORSE; HORSE DISEASE; INFLAMMATION; MALE; METABOLISM; MITOCHONDRION; MUSCLE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; SKELETAL MUSCLE;

ANIMALS; ANOXIA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOTYPE; GLYCOGEN; HORSE DISEASES; HORSES; INFLAMMATION; MALE; MITOCHONDRIA; MUSCLE, SKELETAL; MUSCULAR DISEASES; PHENOTYPE; POLYSACCHARIDES;

EID: 73349142391     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-5-29     Document Type: Article

References (45)

1. Larcher T, Herszberg B, Molon-Noblot S, Guigand L, Chaffaux S, Guerin G, Cherel Y. Polysaccharide Storage Myopathy in Cob Normand Draft Horses. Veterinary Pathology 2008, 45:154-158. 10.1354/vp.45-2-154, 18424827.
2. Valberg SJ, Cardinet GH, Carlson GP, DiMauro S. Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses. Neuromuscular Disorders 1992, 2:351-359. 10.1016/S0960-8966(06)80006-4, 1284408.
3. Valberg SJ, Macleay JM, Billstrom JA, Hower-Moritz MA, Mickelson JR. Skeletal muscle metabolic response to exercise in horses with 'tying-up' due to polysaccharide storage myopathy. Equine veterinary Journal 1999, 31:43-47.
4. Aleman M. A review of equine muscle disorders. Neuromuscular Disorders 2008, 18:277-287. 10.1016/j.nmd.2008.01.001, 18395447.
5. Quiroz-Rothe E, Novales M, Aguilera-Tejero E, Rivero JL. Polysaccharide storage myopathy in the M. longissimus lumborum of showjumpers and dressage horses with back pain. Equine veterinary Journal 2002, 34:171-176. 10.2746/042516402776767259, 11905436.
6. Valentine BA, Cooper BJ. Incidence of polysaccharide storage myopathy: necropsy study of 225 horses. Veterinay Pathology 2005, 42:823-827.
7. McCue ME, Ribeiro WP, Valberg SJ. Prevalence of polysaccharide storage myopathy in horses with neuromuscular disorders. Equine veterinary Journal Supplement 2006, 36:340-344.
8. McCue ME, Valberg SJ. Estimated prevalence of polysaccharide storage myopathy among overtly healthy Quarter Horses in the United States. Journal of American Veterinary Medecine Association 2007, 231(Sept 1):746-750.
9. Firshman AM, Valberg SJ, Bender JB, Annandale EJ, Hayden DW. Comparison of histopathologic criteria and skeletal muscle fixation techniques for the diagnosis of polysaccharide storage myopathy in horses. Veterinary Pathology 2006, 43:257-269. 10.1354/vp.43-3-257, 16672572.
10. Firshman AM, Baird JD, Valberg SJ. Prevalences and clinical signs of polysaccharide storage myopathy and shivers in Belgian draft horses. Journal of American Vetereinary Medecine Association 2005, 227(15):1958-1964.
11. McGowan CM, McGowan TW, Patterson-Kane JC. Prevalence of equine polysaccharide storage myopathy and other myopathies in two equine populations in the United Kingdom. Veterinary Journal 2009, 180(3):330-336.
12. Valentine BA. Diagnosis and treatment of equine polysaccharide storage myopathy. Journal Equine veterinary Science 2005, 25:52-61.
13. Yoon SS. Glycogen storage disease: clinical, biochemichal and molecular heterogeneity. Seminar in Pediatric Neurology 2006, 13:115-120.
14. De La Corte FD, Valberg SJ, MacLeay JM, Williamson SE, Mickelson JR. Glucose uptake in horses with polysaccharide storage myopathy. American Journal of veterinary Research 1999, 60:458-462.
15. Valberg SJ, Townsend D, Mickelson JR. Skeletal muscle glycolytic capacity and phosphofructokinase regulation in horses with polysaccharide storage myopathy. American Journal of veterinary Research 1998, 59:782-5.
16. Annandale EJ, Valberg SJ, Mickelson JR, Seaquist ER. Insulin sensitivity and skeletal muscle glucose transport in horses with equine polysaccharide storage myopathy. Neuromuscular Disorders 2004, 14:666-674. 10.1016/j.nmd.2004.05.007, 15351424.
17. Park HB, Marklund S, Jeon JT, Mickelson JR, Valberg SJ, Sandberg K, Andersson L. Molecular characterization and mutational screening of the PRKAG3 gene in the horse. Cytogenetic and Genome Research 2003, 102:211-216.
18. Dranchak PK, Leiper FC, Valberg SJ, Piercy RJ, Carling D, McCue ME, Mickelson JR. Biochemical and genetic evaluation of the role of AMP-activiated protein kinase in polysaccharide staorag myopathy in Quarter Horses. American Journal of veterinary Research 2007, 68:1079-1084. 10.2460/ajvr.68.10.1079, 17916014.
19. Herszberg B, Mata X, Giulotto E, Decaunes P, Piras FM, Chowdhary BP, Chaffaux S, Guérin G. Characterization of the equine glycogen debranching enzyme gene (AGL): genomic and cDNA structure, localization, polymorphism and expression. Gene 2007, 404(1):1-9. 10.1016/j.gene.2007.07.034, 17905541.
20. Ward TL, Valberg SJ, Adelson DL, Abbey CA, Binns MM, Mickelson JR. Glycogen branching enzyme (GBE1) mutation causing equine glycogen storage disease IV. Mammalian Genome 2004, 15:570-577. 10.1007/s00335-004-2369-1, 15366377.
21. McCue ME, Valberg SJ, Miller MB, Wade C, DiMauro S, Akman HO, Mickelson JR. Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis. Genomics 2008, 91:458-466. 2430182, 18358695, 10.1016/j.ygeno.2008.01.011.
22. Valette JP, Barrey E, Jouglin M, Courouce A, Auvinet B, Flaux B. Standardisation of muscular biopsy of gluteus medius in French trotters. Equine Veterinary Journal Suppl 1999, 30:342-344.
23. Le Brigand K, Russell R, Moreilhon C, Rouillard JM, Jost B, Amiot F, Magnone V, Bole-Feysot C, Rostagno P, Virolle V, Defamie V, Dessen P, Williams G, Lyons P, Rios G, Mari B, Gulari E, Kastner P, Gidrol X, Freeman TC, Barbry P. An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes. Nucleic Acids Research 2006, 34(12):e87. 1524919, 16855282, 10.1093/nar/gkl485.
24. Muller C, Denis M, Gentzbittel L, Faraut T. The Iccare Web server: an attempt to merge sequence and mapping information for plant and animal species. Nucleic Acids Research 2004, 32:W429-W434. 441598, 15215424, 10.1093/nar/gkh460.
25. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of Royal Statistical Society 1995, 57(Ser. B):289-300.
26. Eyles D, Almeras L, Benech P, Patatian A, Mackay-Sim A, McGrath J, Féron F. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. Journal of Steroid Biochemistry and Molecular Biology 2007, 103:538-545.
27. Vandenplas ML, Moore JN, Hurley DJ. Equine cDNA Microarrays for Examining Gene Expression Profiles In Pro-Inflammatory Conditions And Other Diseases. Plant and Animal Genome XIII Conference, Equine session. San Diego 2005, W091.
28. McLeod JN. Equine articular cartilage microarray. Plant and Animal Genome XIII Conference, Equine session. San Diego 2005, W092.
29. Gu W, Bertone AL. Generation and performance of an equine-specific large-scale gene expression microarray. American Journal veterinary Research 2004, 65:1664-1673.
30. Kargul GJ, Dudekula DB, Qian Y, Lim MK, Jaradat SA, Tanaka TS, Carter MG, Ko MS. Verification and initial annotation of the NIA mouse 15k cDNA clone set. Nature Genetics 2001, 28:17-18. 10.1038/88206, 11326268.
31. Mucher E, Jayr L, Rossignol F, Amiot F, Gidrol X, Barrey E. Method of gene expression profiling in equine muscle using cDNA microarrays. Equine veterinary Journal Suppl 2006, 36:359-364.
32. Weiss A, McDonough D, Wertman B, Acakpo-Satchivi L, Montgomery K, Kucherlapati R, Leinwand L, Krauter K. Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. Proceedings of the National Academy of Science USA 1999, 96:2958-2963.
33. Barrey E, Mucher E, Robert C, Amiot F, Gidrol X. Gene expression profiling in blood cells of performer and disqualified endurance horses. Equine veterinary Journal Suppl 2006, 36:43-49.
34. De Paepe B, Creus KK, De Bleecker JL. Chemokines in idiopathic inflammatory myopathies. Front Bioscience 2008, 13:2548-2577.
35. Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J. IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. Journal of Cellular Biology 2003, 163:931-936.
36. Short KR, Moller N, Bigelow ML, Coenen-Schimke J, Nair KS. Enhancement of muscle mitochondrial function by growth hormone. Journal of Clinical Endocrinology and Metabolism 2008, 93:597-604.
37. Boekholdt SM, Peters RJ, Hack CE, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma PH, Khaw KT. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arteriosclerosis and Thrombo Vascular Biolology 2004, 24:1503-1508.
38. Zirlik A, Abdullah SM, Gerdes N, MacFarlane L, Schönbeck U, Khera A, McGuire DK, Vega GL, Grundy S, Libby P, de Lemos JA. Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: Results from the Dallas Heart Study. Arteriosclerosis and Thrombo Vascular Biology 2007, 27:2043-2049.
39. Chandrasekar B, Mummidi S, Claycomb WC, Mestril R, Nemer M. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. Journal of Biological Chemistry 2005, 280(6):4553-4567. 10.1074/jbc.M411787200, 15574430.
40. Schnitzer SE, Schmid T, Zhou J, Eisenbrand G, Brüne B. Inhibition of GSK3beta by indirubins restores HIF-1alpha accumulation under prolonged periods of hypoxia/anoxia. FEBS Letter 2005, 579:529-533.
41. Mottet D, Dumont V, Deccache Y, Demazy C, Ninane N, Raes M, Michiels C. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. Journal of Biological Chemistry 2003, 278(15):31277-3127785. 10.1074/jbc.M300763200, 12764143.
42. Genc S, Koroglu TF, Genc K. Erythropoietin and the nervous system. Brain Research 2004, 1000(12):19-31. 10.1016/j.brainres.2003.12.037, 15053948.
43. Yatsiv I, Grigoriadis N, Simeonidou C, Stahel PF, Schmidt OI, Alexandrovitch AG, Tsenter J, Shohami E. Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. Federation of American Societies of Experimental Biology Journal 2005, 19:1701-1703.
44. Bahlmann FH, Kielstein JT, Haller H, Fliser D. Erythropoietin and progression of CKD. Kidney International Suppl 2007, 107:S21-25.
45. Manolis AS, Tzeis S, Triantafyllou K, Michaelidis J, Pyrros I, Sakellaris N, Kranidis A, Melita H. Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects. Current Drug Targets Cardiovascular and Haematological Disorders 2005, 5:355-375.